Lansforsakringar Fondforvaltning AB (publ)
Position in LLY — ELI LILLY & Co
CIK 2059323
Stockholm, V7
Position in LLY
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$290,423,815
-$46,785,008 QoQ
Shares Held
315,757
+0.6% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
1.57%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Lansforsakringar Fondforvaltning AB (publ) holds $1,479,012,540 across 10 Drug Manufacturers - General names. LLY ranks #2 (19.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
2,438,551 | $480,931,028 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
315,757 | $290,423,815 | |
| 3 | JNJ |
Johnson & Johnson
|
791,412 | $193,452,749 | |
| 4 | ABBV |
AbbVie Inc.
|
566,186 | $123,139,793 | |
| 5 | MRK |
Merck & Co., Inc.
|
804,827 | $96,812,639 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
689,133 | $96,044,466 | |
| 7 | PFE |
Pfizer Inc
|
3,158,825 | $88,699,806 | |
| 8 | AMGN |
Amgen Inc
|
172,718 | $60,770,828 |
All Filings in LLY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $290,423,815 | 315,757 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $337,208,823 | 313,776 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $237,263,243 | 310,961 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $242,788,516 | 311,455 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $286,115,045 | 346,424 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $270,641,584 | 350,572 | Shares | Sole | 2025-04-14 | |
| No filing history on record for this holder in this stock. | ||||||